PYOTT DAVID E I sold ALNY
June 1, 2026 · Form 4 insider transaction
PYOTT DAVID E I sold 17 shares of Alnylam Pharmaceuticals, Inc. at $302.65 per share, a transaction worth $5.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
17
Price
$302.65
Total value
$5.1K
InsiderPYOTT DAVID E I
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after1,582
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025. The options exercised by the reporting person were due to expire on June 3, 2026.